Restatement of Previously Issued Unaudited Condensed Financial Statements (Tables)

6 Months Ended

Dec. 31, 2024

Restatement of Previously Issued Unaudited Condensed Financial Statements [Abstract]

Schedule of Condensed Consolidated Balance Sheet

Management concluded that the previously issued unaudited condensed financial statements for the three and six months ended December 31, 2024 should be restated to correct the following error:

	December 31, 2024
Condensed consolidated balance sheet	As previously reported			Adjustments			As restated
Accounts payable and accrued liabilities	$	7,684,195		$	2,300,000		$	9,984,195
Current liabilities		11,182,502			2,300,000			13,482,502
Total liabilities		17,178,984			2,300,000			19,478,984
Accumulated deficit		(115,498,661	)		(2,300,000	)		(117,798,661	)
Total stockholders’ deficit	$	(974,302	)	$	(2,300,000	)	$	(3,274,302	)

Schedule of Condensed Consolidated Statements of Operations and Comprehensive Income (Loss)

	Three months ended December 31, 2024
Condensed consolidated statements of operations and comprehensive income (loss)	As previously reported		Adjustments			As restated
Transaction costs	$	2,368,895	$	2,300,000		$	4,668,895
Operating expenses		5,477,187		2,300,000			7,777,187
Income (loss) before taxes		32,521,103		(2,300,000	)		30,221,103
Net income (loss)		32,521,108		(2,300,000	)		30,221,108
Comprehensive income (loss)	$	32,522,167	$	(2,300,000	)	$	30,222,167

	Six months ended December 31, 2024
Condensed consolidated statements of operations and comprehensive income (loss)	As previously reported		Adjustments			As restated
Transaction costs	$	3,117,436	$	2,300,000		$	5,417,436
Operating expenses		7,377,128		2,300,000			9,677,128
Income (loss) before taxes		25,108,928		(2,300,000	)		22,808,928
Net income (loss)		25,108,933		(2,300,000	)		22,808,933
Comprehensive income (loss)	$	25,109,992	$	(2,300,000	)	$	22,809,992

Schedule of Condensed Consolidated Statements of Cash Flows

	Six months ended December 31, 2024
Condensed consolidated statements of cash flows	As previously reported			Adjustments			As restated
Operating activities
Net income (loss)	$	25,108,933		$	(2,300,000	)	$	22,808,933
Non-cash transaction cost		1,347,526			2,300,000			3,647,526
Cash used in operating activities	$	(6,636,484	)	$	-		$	(6,636,484	)

Schedule of Condensed Consolidated Statements of Changes in Stockholders’ Deficit

	December 31, 2024
Condensed consolidated statements of changes in stockholders’ deficit	As previously reported			Adjustments			As restated
Net income	$	32,521,108		$	(2,300,000	)	$	30,221,108
Accumulated deficit		(115,498,661	)		(2,300,000	)		(117,798,661	)
Total stockholders’ deficit	$	(974,302	)	$	(2,300,000	)	$	(3,274,302	)